AR127559A1 - Compuestos, composiciones y métodos - Google Patents

Compuestos, composiciones y métodos

Info

Publication number
AR127559A1
AR127559A1 ARP220103009A ARP220103009A AR127559A1 AR 127559 A1 AR127559 A1 AR 127559A1 AR P220103009 A ARP220103009 A AR P220103009A AR P220103009 A ARP220103009 A AR P220103009A AR 127559 A1 AR127559 A1 AR 127559A1
Authority
AR
Argentina
Prior art keywords
compositions
compounds
methods
compound
pharmaceutically acceptable
Prior art date
Application number
ARP220103009A
Other languages
English (en)
Inventor
Anjali Pandey
Biswajit Kalita
Athisayamani Jeyaraj Duraiswamy
Original Assignee
Aria Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aria Pharmaceuticals Inc filed Critical Aria Pharmaceuticals Inc
Publication of AR127559A1 publication Critical patent/AR127559A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto de la fórmula (1). Reivindicación 35: Una composición farmacéutica que comprende un compuesto de cualquier reivindicación anterior, o una sal farmacéuticamente aceptable, estereoisómero, mezcla de estereoisómeros o profármaco de este, y un portador farmacéuticamente aceptable.
ARP220103009A 2021-11-02 2022-11-02 Compuestos, composiciones y métodos AR127559A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163274916P 2021-11-02 2021-11-02

Publications (1)

Publication Number Publication Date
AR127559A1 true AR127559A1 (es) 2024-02-07

Family

ID=84364211

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220103009A AR127559A1 (es) 2021-11-02 2022-11-02 Compuestos, composiciones y métodos

Country Status (3)

Country Link
AR (1) AR127559A1 (es)
TW (1) TW202334135A (es)
WO (1) WO2023081666A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE424401T1 (de) * 2002-07-16 2009-03-15 Amura Therapeutics Ltd Pyrrolderivate als hemmstoffe von cystein proteasen
JP4828829B2 (ja) * 2002-11-27 2011-11-30 インサイト・コーポレイション ケモカイン受容体のモジュレーターとしての３−アミノピロリジン誘導体
EP2685828A4 (en) * 2011-03-17 2014-08-13 Merck Sharp & Dohme SUBSTITUTED 3-AZABICYCLO [3,1,0-] HEXAN DERIVATIVES AS CCR2 ANTAGONISTS

Also Published As

Publication number Publication date
TW202334135A (zh) 2023-09-01
WO2023081666A1 (en) 2023-05-11

Similar Documents

Publication Publication Date Title
MX2022014458A (es) Derivados de triazina que tienen actividad inhibidora de la replicacion del virus y composicion farmaceutica que constituye el mismo.
UY38297A (es) Compuestos derivados de 3-(5-hidroxi-1-oxoisoindolin-2-il)piperidina-2,6-diona, composiciones, métodos y usos de los mismos
ECSP20044709A (es) Inhibidores de sarcómero cardíaco
AR056873A1 (es) Derivados de pirazolopirimidinas como inhibidores de quinasa dependientes de ciclina, composiciones farmaceuticas
MX2022001784A (es) Piperidinil-metil-purinaminas como inhibidores de nsd2 y antineoplásicos.
MX2020009530A (es) Inhibidores de la o-glicoproteína-2-acetamido-2-desoxi-3-dglicopir anosidasa.
AR122351A1 (es) Derivados de metilquinazolinona como inhibidores de braf
MX2022004451A (es) Heteroaril-bifenil-amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1.
MX2020011317A (es) Compuestos heterociclicos triciclicos utiles como inhibidores de la integrasa de vih.
MX2022004450A (es) Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1.
UY27577A1 (es) Inhibidores de la integrasa del vih
ECSP22032016A (es) Inhibidor de irak y método de preparación para el mismo y uso del mismo
CO2023000854A2 (es) Nuevo derivado de pirazol
CO2022008616A2 (es) Composición farmacéutica oral que comprende compuesto de carbamato y método de preparación para la misma
EA202192530A1 (ru) Соединения, композиции и способы
CL2022000893A1 (es) Derivados de 2-azaspiro[3,4]octano como agonistas de m4
CO2023016088A2 (es) Compuestos de espiroindolinona como bloqueadores del canal agitador de potasio kv1.3
MX2022008487A (es) Degradadores de smarca2-vhl.
AR116428A1 (es) Compuestos de 6-fluoro-2-metilbenzo[d]tiazol-5-ilo
AR127559A1 (es) Compuestos, composiciones y métodos
WO2020251871A3 (en) Novel substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
CR20210181A (es) Inhibidores de o-glicoproteína-2-acetamido-2-desoxi-3-d-glucopiranosidasa
AR126914A1 (es) Inhibidores de ras novedosos
WO2022104153A3 (en) Compounds and methods for treating viral infections
CR20230218A (es) Nuevos derivados de indazol acetileno

Legal Events

Date Code Title Description
FB Suspension of granting procedure